risk stratification
ACMG Workgroup Addresses Cancer Risk Variability With CHEK2 Alterations in Practice Resource
The workgroup reviewed the available evidence and recommended clinicians manage patients based on the type of variants they have along with family history and other factors.
Pacific Edge Ramps up Clinical Utility Studies, Commercial Efforts Behind Bladder Cancer Test
Premium
The New Zealand-based diagnostics firm is hoping the coming year will be a tipping point toward new guideline inclusion and broader adoption.
A score developed using UK Biobank data can identify patients at high and low risk for blood cancer progression and is starting to be used at Dana-Farber Cancer Institute.
COPD Risk Loci Uncovered With GWAS, Machine Learning-Based Phenotyping
Using a machine learning model for distinguishing individuals with or without COPD, researchers identified dozens of new and known risk loci.
Unique inflammation-associated gene expression signatures in adult and pediatric AML patients may speed risk stratification and treatment decisions.